« Eurostar grant | Main | Danish government grant »
Saturday
Jun112011

Technology Foundation grant

MinervaX announces the award of a grant from The Danish National Advanced Technology Foundation together with The State Serum Institute and University of Copenhagen for the development and testing of a CAF Adjuvant formulation of the NN GBS vaccine as well as a Chlamydia vaccine candidate. The total grant budget amounts to 29.6 mDKK (3.9 mEUR).

Press release